3.00
-0.515(-14.65%)
Currency In USD
| Previous Close | 3.52 |
| Open | 3.55 |
| Day High | 3.58 |
| Day Low | 2.9 |
| 52-Week High | 6.9 |
| 52-Week Low | 1.96 |
| Volume | 154,473 |
| Average Volume | 89,194 |
| Market Cap | 6.97M |
| PE | -0.79 |
| EPS | -3.8 |
| Moving Average 50 Days | 3.63 |
| Moving Average 200 Days | 3.43 |
| Change | -0.52 |
If you invested $1000 in Creative Medical Technology Holdings, Inc. (CELZ) since IPO date, it would be worth $0.36 as of March 13, 2025 at a share price of $3. Whereas If you bought $1000 worth of Creative Medical Technology Holdings, Inc. (CELZ) shares 5 years ago, it would be worth $50 as of March 13, 2025 at a share price of $3.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
GlobeNewswire Inc.
Mar 06, 2025 1:10 PM GMT
PHOENIX, March 06, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a leading biotechnology innovator in regenerative medicine, today announced it has entered into agreements with certain holders
Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
GlobeNewswire Inc.
Feb 20, 2025 1:00 PM GMT
OvaStem® Demonstrates Strong Long-Term Efficacy with No Safety Concerns, Backed by Pending Orphan Drug Designation for AlloStem®PHOENIX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a leading biotechn
Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
GlobeNewswire Inc.
Feb 14, 2025 12:00 PM GMT
Study Demonstrates Robust Efficacy and Strong Safety ProfilePHOENIX, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a pioneering biotechnology firm speci